Enhanced immunization after intranasal coadministration of Escherichia coli heat-labile enterotoxin B subunit and human papillomavirus 16-L1 DNA vaccine 被引量：2

Enhanced immunization after intranasal coadministration of Escherichia coli heat-labile enterotoxin B subunit and human papillomavirus 16-L1 DNA vaccine

原文传递

导出

摘要 Human papillomavirus （HPV）, mainly types 16 and 18, are the most important initiating agents of cervical cancer. Prevention of high-risk HPV infections is a potentially effective approach to control HPV associated cervical cancer. Human papillomavirus （HPV）, mainly types 16 and 18, are the most important initiating agents of cervical cancer. Prevention of high-risk HPV infections is a potentially effective approach to control HPV associated cervical cancer.

作者 WANG Jing ZHAO Chang-an WANG Kai ZHENG Jin WANG Yi-li SI Lü-sheng

机构地区 Key Laboratory of Biomedical Information Engineering of Education Ministry

出处《Chinese Medical Journal》 SCIE CAS CSCD 2006年第5期408-411,共4页 中华医学杂志（英文版）

关键词 Escherichia coil heat-labile enterotoxin B subunit human papillomavirus type 16 DNA vaccines Escherichia coil heat-labile enterotoxin B subunit human papillomavirus type 16 DNA vaccines

分类号 R373 [医药卫生—病原生物学]

引文网络
相关文献

参考文献2

1JinZHENG JunMA Xiao-FengYANG Hong-WeiCHENG Lu-ShengSIt Yi-LiWANG.Highly Efficient and Economical Baculovirus Expression System for Preparing Human Papillomavirus Type16 Virus-like Particle[J].Acta Biochimica et Biophysica Sinica,2004,36(8):548-552. 被引量：7
2王静,李琳琳,郑瑾,于军,杨筱凤,耿宜平,来宝长,王一理,司履生.Highly efficient expression, purification of recombinant LTB protein and its activity against mucosal immunoadjuvant by nasal immunization[J].Chinese Medical Journal,2003(7):1115-1117. 被引量：7

二级参考文献9

1McCance DJ. Human papillomaviruses and cervical cancer. J Med Microbiology, 1998, 47(5): 371-373.
2Sanclemente G, Gill DK. Human papillomavirus molecular biology and pathogenesis. J Eur Acad Dermatol Venereol, 2002, 16(3): 231-240.
3Hagensee ME, Yaegashi N, Galloway DA. Self-assembly of human papillomavirus type 1 capsids by expression of the LI protein alone or by coexpression of the L 1 and L2 capsid proteins. J Virol, 1993; 67( 1 ): 315-322.
4le Cann P, Coursaget P, lochmann S, Touze A. Self-assembly of human papillomavirus type 16 capsids by expression of the L 1 protein in insect cells.FEMS Microbiol Lett, 1994, 117(3): 269-274.
5Zheng B, Wang JW, Jiang HY, Qu JG, Wang YL, Si LS, Dong XP.Expression of human papillomavirus type16 L I protein by insect-baculovirus expression system. Chinese J Exp Clin Virol (Chin), 2001, 15(4): 314-317.
6Roden RB, Hubbert NL, Kirnbauer R, Breitburd F, Lowy DR, Schiller JT.Papillomavirus L 1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor. J Virol, 1995, 69(8): 5147-5151.
7Breitburd F, Kirnbauer R, Hubbert NL, Nonnenmacher B, Trin-Dinh-Desmarquet C, Orth G, Schiller JT et al. Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol, 1995, 69(6): 3959-3963.
8Kirnbauer R, Chandrachud LM, O'Neil BW, Wagner ER, Grindlay GJ.Armstrong A, McGarvie GM et al. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology, 1996, 219(1): 37-44.
9Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB.Chiacchierini LM et al. A controlled trial of a human papillomavirus type 16vaccine. N Engl J Med, 2002, 347(21): 1645-1651.

共引文献10

1刘红莉,雷霆,张铮,郑瑾,来宝长,孔令洪,王喆之,王一理,司履生.LT-B转基因烟草植株的建立[J].西安交通大学学报（医学版）,2004,25(5):425-429. 被引量：4
2Hong-LiLIU,Wen-ShengLI,TingLEI,JingZHENG,ZhengZHANG,Xiao-FeiYAN,Zhe-ZhiWANG,Yi-LiWANG,Lii-ShengSI.Expression of Human Papillomavirus Type 16 L1 Protein in Transgenic Tobacco Plants[J].Acta Biochimica et Biophysica Sinica,2005,37(3):153-158. 被引量：3
3司履生.肿瘤免疫研究的回顾与展望[J].西安交通大学学报（医学版）,2005,26(2):97-100. 被引量：6
4杨筱凤,陈宏伟,郑瑾,司履生,董小平,王一理.人乳头瘤病毒16L1-减毒志贺氏杆菌为载体疫苗的构建及免疫效应初步鉴定[J].病毒学报,2005,21(3):198-203. 被引量：5
5刘红莉,张铮,李文生,郑瑾,孔令洪,王一理,司履生.Expression of E. coli heat-labile enterotoxin B subunit in transgenic tobacco plants[J].Journal of Medical Colleges of PLA(China),2005,20(5):262-267.
6Xiao-Feng YANG,Xin-Zhong QU,Kai WANG,Jin ZHENG,Lu-Sheng SI,Xiao-Ping DONG,Yi-Li WANG.Construction of Prophylactic Human Papillomavirus Type 16 L1 Capsid Protein Vaccine Delivered by Live Attenuated Shigella flexneri Strain sh42[J].Acta Biochimica et Biophysica Sinica,2005,37(11):743-750. 被引量：5
7唐思静,刘惠莉.大肠埃希菌热敏性肠毒素B亚基研究进展[J].动物医学进展,2008,29(2):68-72. 被引量：3
8Jin Zheng,Xiaofeng Yang,Ying Sun,Baochang Lai,Yili Wang.Stable high-level expression of truncated human papillomavirus type 16 L1 protein in Drosophila Schneider-2 cells[J].Acta Biochimica et Biophysica Sinica,2008,40(5):437-442. 被引量：6
9闫小飞,徐阳,郑瑾,来宝长,王一理.型特异性、构象依赖性HPV16 L1单克隆抗体的制备与鉴定[J].细胞与分子免疫学杂志,2009,25(12):1133-1135.
10王法权,刘琳琳.内置式佐剂LTB对空肠弯曲菌重组蛋白疫苗免疫增强作用的研究[J].山东医学高等专科学校学报,2012,34(1):12-14. 被引量：3

同被引文献9

1王星,覃宗华,刘定发.大肠杆菌不耐热肠毒素的分子生物学及粘膜免疫佐剂效应[J].广东畜牧兽医科技,2005,30(4):18-21. 被引量：7
2张锦霞,郭学军,李毅,祝令伟,齐冲,刘军,孙洋,冯书章.大肠杆菌不耐热肠毒素B亚单位在原核细胞中的高效表达[J].中国预防兽医学报,2006,28(2):160-163. 被引量：4
3张莹丹,徐维明,李健峰.大肠埃希菌不耐热肠毒素研究进展[J].动物医学进展,2007,28(2):85-88. 被引量：6
4赵艳敏,刘惠莉.大肠埃希菌不耐热肠毒素作为黏膜免疫佐剂的研究进展[J].动物医学进展,2007,28(3):46-50. 被引量：11
5牛登元,王一成,袁秀芳,徐丽华,刘邓,伏小平.PRRSV浙江株ORF5基因的原核表达与免疫原性分析[J].浙江农业学报,2009,21(2):126-129. 被引量：1
6王玉炯,许崇波.大肠杆菌耐热性肠毒素(ST)的分子生物学研究进展[J].宁夏大学学报（自然科学版）,2001,22(3):331-336. 被引量：9
7许崇波,卫广森,王文成,王卓.表达大肠杆菌K88ac-ST_1-LT_B融合蛋白工程菌株的免疫原性研究[J].中国预防兽医学报,2003,25(1):9-12. 被引量：5
8石振华,李尚波,苏钢,赵宝华,王文成,卫广森,许崇波.表达无毒性大肠杆菌ST1-LTB融合蛋白基因工程菌株的构建[J].中国预防兽医学报,2003,25(5):341-344. 被引量：2
9王静,李琳琳,郑瑾,于军,杨筱凤,耿宜平,来宝长,王一理,司履生.Highly efficient expression, purification of recombinant LTB protein and its activity against mucosal immunoadjuvant by nasal immunization[J].Chinese Medical Journal,2003(7):1115-1117. 被引量：7

引证文献2

1唐思静,刘惠莉.大肠埃希菌热敏性肠毒素B亚基研究进展[J].动物医学进展,2008,29(2):68-72. 被引量：3
2王朝文,吴润,王一成,袁秀芳,徐丽华,李军星,路斌.大肠杆菌LTB增强PRRSV-GP5蛋白免疫反应的研究[J].甘肃农业大学学报,2010,45(6):12-17. 被引量：2

二级引证文献5

1师小潇,哈卓,丁长根,潘洁,饶柏忠,刘惠莉.猪流感病毒多表位融合蛋白对小鼠的免疫原性分析[J].畜牧兽医学报,2011,42(9):1284-1288.
2唐思静,刘惠莉,马勋,赵艳敏.大肠杆菌不耐热肠毒素突变体的原核表达及其活性研究[J].中国预防兽医学报,2012,34(9):697-701. 被引量：6
3张鲁滨,王一成,吴润,李军星,袁秀芳,徐丽华.重组猪α干扰素的酵母表达及其对伪狂犬病毒的抑制作用[J].甘肃农业大学学报,2012,47(4):1-6. 被引量：4
4周晓丽,王一成,姜平,袁秀芳,李军星,杜晓莉.大肠杆菌不耐热肠毒素B亚单位对鸭禽流感疫苗的免疫效果[J].畜牧与兽医,2014,46(5):98-101. 被引量：2
5殷秀辰,哈卓,李星,张清真,刘惠莉.含粘膜佐剂的鸡新城疫疫苗诱导雏鸡非特异性免疫应答的研究[J].中国动物传染病学报,2014,22(5):35-40. 被引量：1

1马列婷,于燕,杨朵,王林川,王亚文.大肠埃希菌超广谱β-内酰胺酶的检测和耐药性分析[J].中国基层医药,2008,15(9):1438-1439. 被引量：1
2边锋芝,苑广盈.大肠埃希菌、肺炎克雷伯菌超广谱β-内酰胺酶的检测和耐药性监测分析[J].国际检验医学杂志,2008,29(6):484-486. 被引量：6
3钟桂香,张英芬.三种方法检测细菌超广谱β-内酰胺酶的比较分析[J].中国误诊学杂志,2008,8(30):7327-7328.
4王馥香.365株大肠埃希菌的耐药性分析[J].国际检验医学杂志,2010,31(8):876-877. 被引量：12
5安新,熊自忠,曹鸿霞.大肠埃希菌对氟喹诺酮类和阿米卡星的耐药性分析[J].中国基层医药,2008,15(4):540-541. 被引量：1
6崔惠景,张芳,常军霞.住院与社区泌尿系感染大肠埃希菌耐药状况对比分析[J].国际检验医学杂志,2013,34(10):1305-1306.
7李红,王贝,阿不都拉.大肠埃希菌在泌尿系统感染中的耐药性分析[J].国际检验医学杂志,2010,31(8):890-891. 被引量：6
8管欣娴,俞生林,汪健,高沙沙,李毅平.大肠埃希菌致脓毒症新生大鼠巨噬细胞及血中CD163表达研究[J].中国新生儿科杂志,2016,31(5):375-378.
9李岷,李克涓,赵苏瑛.大肠埃希菌和克雷伯菌ESBLs及AmpC酶的检测[J].国际检验医学杂志,2009,30(11):1122-1123. 被引量：3
10邢晋苓,周建明.142株大肠埃希菌耐药性分析[J].国际检验医学杂志,2009,30(12):1202-1203. 被引量：2

Chinese Medical Journal

2006年第5期

浏览历史

内容加载中请稍等...